Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles, respectively, in the development and regulation of skeletal muscle mass. The findings of Sun et al. in this issue shed light on the potential regulation and actions of this yin-and-yang system in uremic sarcopenia and the salutary effects of exercise
International audienceChronic kidney disease (CKD) patients often exhibit a low muscle mass and stre...
Background and Aims Patients with end-stage kidney disease (ESKD) show skeletal muscle abnormalities...
<div><p>Objectives</p><p>Myostatin (MSTN), a member of TGF-β superfamily, is produced in the skeleta...
Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles,...
BACKGROUND: Sarcopenia increases as renal function declines and is associated with higher morbidity ...
Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may functi...
“Uremic sarcopenia” refers to a progressive decrease in muscle mass, strength, and function despite ...
The loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute t...
International audienceOBJECTIVE: Muscle strength is frequently altered in hemodialysis patients. In ...
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis pat...
National audienceOBJECTIVE: Muscle strength is frequently altered in hemodialysis patients. In the p...
Background: Malnutrition and muscle wasting are common in haemodialysis (HD) patients. Their pathoge...
Myostatin (MSTN), a member of TGF-β superfamily, is produced in the skeletal muscle to inhibit myocy...
Recent publications of consensus documents for the re-definition of myocardial infarction are heavil...
Sarcopenia or muscle wasting is a progressive and generalized skeletal muscle disorder involving the...
International audienceChronic kidney disease (CKD) patients often exhibit a low muscle mass and stre...
Background and Aims Patients with end-stage kidney disease (ESKD) show skeletal muscle abnormalities...
<div><p>Objectives</p><p>Myostatin (MSTN), a member of TGF-β superfamily, is produced in the skeleta...
Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles,...
BACKGROUND: Sarcopenia increases as renal function declines and is associated with higher morbidity ...
Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may functi...
“Uremic sarcopenia” refers to a progressive decrease in muscle mass, strength, and function despite ...
The loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute t...
International audienceOBJECTIVE: Muscle strength is frequently altered in hemodialysis patients. In ...
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis pat...
National audienceOBJECTIVE: Muscle strength is frequently altered in hemodialysis patients. In the p...
Background: Malnutrition and muscle wasting are common in haemodialysis (HD) patients. Their pathoge...
Myostatin (MSTN), a member of TGF-β superfamily, is produced in the skeletal muscle to inhibit myocy...
Recent publications of consensus documents for the re-definition of myocardial infarction are heavil...
Sarcopenia or muscle wasting is a progressive and generalized skeletal muscle disorder involving the...
International audienceChronic kidney disease (CKD) patients often exhibit a low muscle mass and stre...
Background and Aims Patients with end-stage kidney disease (ESKD) show skeletal muscle abnormalities...
<div><p>Objectives</p><p>Myostatin (MSTN), a member of TGF-β superfamily, is produced in the skeleta...